planning cycle

Market Access

Approval may validate the science, but it does not secure commercial success. That outcome is determined by the decisions made before launch.

Sales & Marketing

It’s about that time of year when many global teams turn their attention towards annual strategic planning.

News

Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.